OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global absence and targeting of protective immune states in severe COVID-19
Alexis J. Combes, Tristan Courau, Nicholas F. Kuhn, et al.
Nature (2021) Vol. 591, Iss. 7848, pp. 124-130
Open Access | Times Cited: 247

Showing 1-25 of 247 citing articles:

Dictionary learning for integrative, multimodal and scalable single-cell analysis
Yuhan Hao, Tim Stuart, Madeline H. Kowalski, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 2, pp. 293-304
Open Access | Times Cited: 1206

Diverse functional autoantibodies in patients with COVID-19
Eric Y. Wang, Tianyang Mao, Jon Klein, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 283-288
Open Access | Times Cited: 814

Autophagy in inflammation, infection, and immunometabolism
Vojo Deretić
Immunity (2021) Vol. 54, Iss. 3, pp. 437-453
Open Access | Times Cited: 548

Unexplained post-acute infection syndromes
Jan Choutka, Viraj Jansari, Mady Hornig, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 911-923
Open Access | Times Cited: 406

Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Carly G.K. Ziegler, Vincent N. Miao, Anna H. Owings, et al.
Cell (2021) Vol. 184, Iss. 18, pp. 4713-4733.e22
Open Access | Times Cited: 276

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
Paul Bastard, Elizaveta Orlova, Leila Sozaeva, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 7
Open Access | Times Cited: 252

Monocytes and Macrophages in COVID-19
Rainer Knoll, Joachim L. Schultze, Jonas Schulte-Schrepping
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235

The interferon landscape along the respiratory tract impacts the severity of COVID-19
Benedetta Sposito, Achille Broggi, Laura Pandolfi, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4953-4968.e16
Open Access | Times Cited: 233

High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages
Willianne Hoepel, Hung‐Jen Chen, Chiara E. Geyer, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 596
Open Access | Times Cited: 212

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Monique G.P. van der Wijst, Sara E. Vazquez, George C. Hartoularos, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 612
Open Access | Times Cited: 196

Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19
Sarthak Sinha, Nicole L. Rosin, Rohit Arora, et al.
Nature Medicine (2021) Vol. 28, Iss. 1, pp. 201-211
Open Access | Times Cited: 190

Immune signatures underlying post-acute COVID-19 lung sequelae
In Su Cheon, Chaofan Li, Young Min Son, et al.
Science Immunology (2021) Vol. 6, Iss. 65
Open Access | Times Cited: 142

Immunology of SARS-CoV-2 infection in children
Janet Chou, Paul G. Thomas, Adrienne G. Randolph
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 177-185
Open Access | Times Cited: 141

The intersection of COVID-19 and autoimmunity
Jason S. Knight, Roberto Caricchio, Jean‐Laurent Casanova, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 24
Open Access | Times Cited: 111

Discovering dominant tumor immune archetypes in a pan-cancer census
Alexis J. Combes, Bushra Samad, Jessica Tsui, et al.
Cell (2021) Vol. 185, Iss. 1, pp. 184-203.e19
Open Access | Times Cited: 109

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
Alberto Pérez‐Gómez, Joana Vitallé, Carmen Gasca‐Capote, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 9, pp. 2128-2139
Open Access | Times Cited: 105

SARS‐CoV‐2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage
Juan Ma, Fangrui Zhu, Min Zhao, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 100

Single-Cell Analysis Reveals the Range of Transcriptional States of Circulating Human Neutrophils
Gustaf Wigerblad, Qilin Cao, Stephen R. Brooks, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 4, pp. 772-782
Open Access | Times Cited: 83

Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 59

Strategies of neutrophil diversification
Miguel Palomino‐Segura, Jon Sicilia, Iván Ballesteros, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 575-584
Open Access | Times Cited: 55

Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC
Lena Horvath, Constanze Puschmann, Alexandra Scheiber, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 457-474
Open Access | Times Cited: 14

Single-cell immunology of SARS-CoV-2 infection
Yuan Tian, Lindsay N. Carpp, Helen E. R. Miller, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 1, pp. 30-41
Open Access | Times Cited: 100

Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
Rainer Kaiser, Alexander Leunig, Kami Pekayvaz, et al.
JCI Insight (2021) Vol. 6, Iss. 18
Open Access | Times Cited: 91

Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate
Puja Mehta, David C. Fajgenbaum
Current Opinion in Rheumatology (2021) Vol. 33, Iss. 5, pp. 419-430
Open Access | Times Cited: 76

Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
Jon Hazeldine, Janet M. Lord
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73

Page 1 - Next Page

Scroll to top